NIH Clinical Center: Search the Studies

Search the Studies

27 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.

Protocol Number	Title	Protocol Status	Min-Max Age	Institute	Keywords
001731-C	18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection	Recruitment has not started	18-120 Years	NCI	Bladder
001535-C	A Phase II Study of Sacituzumab Govitecan with or without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) such as Small Cell, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile Cancer	Recruitment has not started	18-120 Years	NCI	Bladder
001533-C	A Phase II Multicenter Study of Enfortumab Vedotin with or without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)	Recruitment has not started	18-120 Years	NCI	Bladder
001523-C	A Phase II Study of Lurbinectedin with or without Avelumab in Small Cell Carcinoma of the Bladder (LASER)	Participants currently recruited/enrolled	18-120 Years	NCI	Bladder
001004-C	A Phase 1b/2 Basket Study of ACR-368 as Monotherapy and in Combination with Gemcitabine in Adult Subjects with Platinum-Resistant Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma Based on Acrivon Oncosignature(R) Status	Participants currently recruited/enrolled	18-120 Years	NCI	Bladder
000302-C	A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies	Participants currently recruited/enrolled	18-125 Years	NCI	Bladder
21-C-0017	Magnetic Resonance Image (MRI) Guided High Energy Ultrasound for Focal Prostate Cancer Ablation	Participants currently recruited/enrolled	18-125 Years	NCI	Bladder
20-C-0020	Ex-Vivo Trial of En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device	Participants currently recruited/enrolled	18-125 Years	NCI	Bladder
20-C-0012	A Phase I Study of Bintrafusp alfa (M7824) and NHS-IL12 (M9241) Alone and in Combination with Stereotactic Body Radiation Therapy (SBRT) in Adults with Metastatic Non-Prostate Genitourinary Malignancies	Participants currently recruited/enrolled	18-125 Years	NCI	Bladder
19-C-0137	A Phase II Study of Ipilimumab, Cabozantinib, and NIvolumab in Rare Genitourinary Cancers (ICONIC)	Participants currently recruited/enrolled	18-125 Years	NCI	Bladder
19-C-0023	A Phase II Study of Olaparib (AZD2281) in Patients with Metastatic/Advanced Urothelial Carcinoma and other genitourinary tumors with DNA-Repair Defects	Participants currently recruited/enrolled	18-125 Years	NCI	Bladder
18-CH-0120	A Natural History of the Collagen-Related Disorder Osteogenesis Imperfecta and the Genotype-Phenotype Correlation	Completed Study; data analyses ongoing	0-120 Years	NICHD	Bladder
18-CC-0117	PET Imaging of the Dopaminergic and Serotonergic Systems in Treated HIV Positive Subjects	Completed Study; data analyses ongoing	18-70 Years	CC	Bladder
18-C-0008	Phase III Randomized Adjuvant study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) versus Observation	No longer recruiting/follow-up only	18-125 Years	NCI	Bladder
17-C-0157	A Phase I Single-Arm Study of the Combination of Durvalumab (MEDI4736) and Vicineum (oportuzumab monatox, VB4-845) in Subjects with High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated with Bacillus Calmette-Gu(SqrRoot)(Copyright)rin (BCG)	Completed Study; data analyses ongoing	18-125 Years	NCI	Bladder
17-C-0070	Phase II Trial of Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer with Positive Peritoneal Cytology	No longer recruiting/follow-up only	18-125 Years	NCI	Bladder
16-CC-0098	Pilot Study of Ultrasound Guided Focal Thermal Ablation of Prostate Cancer	Clinical hold/Recruitment or enrollment suspended	18-100 Years	CC	Bladder
16-C-0121	A Pilot Clinical Trial of Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma	Completed Study; data analyses ongoing	18-125 Years	NCI	Bladder
16-C-0107	A Phase I/II Trial of EP0057, a Nanoparticle Camptothecin with Olaparib in Patients with Relapsed/Refractory Small Cell Lung, Bladder and Prostate Cancers	Participants currently recruited/enrolled	18-125 Years	NCI	Bladder
15-C-0160	A Phase I Study of Cabozantinib Plus Nivolumab (CaboNivo) Alone or in Combination with Ipilimumab (CaboNivoIpi) in Patients with Advanced/Metastatic Urothelial Carcinoma and other Genitourinary Tumors	No longer recruiting/follow-up only	18-125 Years	NCI	Bladder
15-C-0087	Care of the Urothelial Cancer Patient and Prospective Collection of Biospecimens from Healthy Volunteers and Urothelial Cancer Patients	Participants currently recruited/enrolled	18-125 Years	NCI	Bladder
14-C-0036	A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillus Calmette-Guerin (BCG) Given in Combination with PANVAC[TM] Versus BCG Given Alone in Adults with High Grade Non-Muscle Invasive Bladder Cancer (NMIBC) Who Failed at Least 1 I	Completed Study; data analyses ongoing	18-125 Years	NCI	Bladder
13-C-0131	Inpatient Hospice with Procurement of Tissue on Expiration in Thoracic Malignancies, Bladder Cancer, Ovarian Cancer, Epithelial Cancer and Patients Treated with an Adoptive Cellular Therapy	Participants currently recruited/enrolled	18-120 Years	NCI	Bladder
12-C-0205	A Phase II Study of Cabozantinib (XL184) in Patients With Advanced/Metastatic Urothelial Carcinoma	Completed Study; data analyses ongoing	18-125 Years	NCI	Bladder
11-C-0140	A Phase I Study of Gemcitabine, Carboplatin and Lenalidomide (GCL) for Treatment of Patients with Advanced/Metastatic Urothelial Carcinoma (UC) and Other Solid Tumors	Completed Study; data analyses ongoing	18-125 Years	NCI	Bladder
99-C-0128	Evaluation for NCI Surgery Branch Clinical Research Protocols	Participants currently recruited/enrolled	18-125 Years	NCI	Bladder
97-C-0147	Collection of Serum and Tissue Samples from Patients with Biopsy-Proved or Suspected Malignant Diseases	Participants currently recruited/enrolled	2-125 Years	NCI	Bladder